MedPath

The influence of mannose-binding lectin (MBL) on the course of disease in patients with cystic fibrosis (CF).

Conditions
Mannose-binding lectin deficiency / deficit of a protein of the immune system
10040792
10021460
10019815
Registration Number
NL-OMON29945
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
170
Inclusion Criteria

patients with cystic fibrosis

Exclusion Criteria

inability/unwillingness to donate blood

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>1. Frequency and severity of infection<br /><br>2. Lung transplantation</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints<br /><br>1. Severity CF<br /><br>2. Phagocytosis of micro-organisms, specific for CF</p><br>
© Copyright 2025. All Rights Reserved by MedPath